- Home
- SMTI vs ACIU Comparison
SMTI vs ACIU Comparison
Compare SMTI & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- ACIU
- Stock Information
- Founded
- SMTI 1982
- ACIU 2003
- Country
- SMTI United States
- ACIU Switzerland
- Employees
- SMTI N/A
- ACIU N/A
- Industry
- SMTI Medical/Dental Instruments
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- SMTI Health Care
- ACIU Health Care
- Exchange
- SMTI Nasdaq
- ACIU Nasdaq
- Market Cap
- SMTI 288.2M
- ACIU 332.4M
- IPO Year
- SMTI N/A
- ACIU 2016
- Fundamental
- Price
- SMTI $34.20
- ACIU $2.71
- Analyst Decision
- SMTI Strong Buy
- ACIU Strong Buy
- Analyst Count
- SMTI 2
- ACIU 2
- Target Price
- SMTI $47.00
- ACIU $12.00
- AVG Volume (30 Days)
- SMTI 31.6K
- ACIU 130.0K
- Earning Date
- SMTI 11-12-2024
- ACIU 11-05-2024
- Dividend Yield
- SMTI N/A
- ACIU N/A
- EPS Growth
- SMTI N/A
- ACIU N/A
- EPS
- SMTI N/A
- ACIU N/A
- Revenue
- SMTI $78,056,873.00
- ACIU $48,505,404.00
- Revenue This Year
- SMTI $29.95
- ACIU $85.33
- Revenue Next Year
- SMTI $19.68
- ACIU $80.69
- P/E Ratio
- SMTI N/A
- ACIU N/A
- Revenue Growth
- SMTI 24.66
- ACIU 4097200.00
- 52 Week Low
- SMTI $26.00
- ACIU $2.25
- 52 Week High
- SMTI $43.25
- ACIU $5.14
- Technical
- Relative Strength Index (RSI)
- SMTI 47.55
- ACIU 29.89
- Support Level
- SMTI $31.13
- ACIU $2.62
- Resistance Level
- SMTI $35.08
- ACIU $3.07
- Average True Range (ATR)
- SMTI 1.84
- ACIU 0.15
- MACD
- SMTI -0.17
- ACIU -0.04
- Stochastic Oscillator
- SMTI 48.19
- ACIU 17.24
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.